California Attorney General Rob Bonta, in collaboration with the United States Department of Justice, announced a settlement with national pharmacy chain CVS Pharmacy over its alleged violations of the California False Claims Act. The settlement resolves allegations that between 2010 and 2021, CVS submitted pharmacy claims to Medi-Cal using false electronic certifications that certified that patients had medical conditions qualifying for the payment of pharmaceutical drugs under Medi-Cal. CVS knowingly failed to verify or document mandatory compliance for a large number of claims, resulting in the payment of millions of dollars of false claims by Medi-Cal. The settlement agreement requires CVS to pay $18.2M. “Today’s settlement holds CVS accountable for its fraudulent drug dispensing and billing practices,” said Attorney General Bonta. “Pharmacies have an important responsibility to ensure all claims they submit to Medi-Cal are verified, true, accurate, and well documented. These practices ensure safe and cost-effective prescription drug use and are essential in ensuring Medi-Cal funds go to people who actually need them. My office is committed to protecting the integrity of the Medi-Cal program and recovering ill-gotten funds.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Trump Weekly: President set to cut tariffs on beef, coffee
- CVS Health price target lowered to $102 from $103 at Wells Fargo
- CVS Health: Strategic Positioning and Growth Potential Justify Buy Rating Despite Challenges
- Trump Trade: Trump says ‘enrichment’ of health insurers ‘must stop’
- Video: Health insurers weighed on by shutdown news, Trump post
